We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+26.9%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$202M
AUM Growth
+$34.9M
Cap. Flow
+$7.29M
Cap. Flow %
3.61%
Top 10 Hldgs %
43.02%
Holding
86
New
26
Increased
16
Reduced
19
Closed
17

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$10.7M
2
AET
Aetna Inc
AET
+$6.28M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$2.94M
4
CAH icon
Cardinal Health
CAH
+$2.36M
5
JUNO
Juno Therapeutics, Inc.
JUNO
+$2.14M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$7.07M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.48M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.09M
4
ELV icon
Elevance Health
ELV
+$2.88M
5
MZOR
Mazor Robotics Ltd.
MZOR
+$2.76M

Sector Composition

Rank Sector Weight
1 Healthcare 66.28%
2 Financials 3.15%
3 Energy 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
26
DELISTED
Esperion Therapeutics
ESPR
$2.65M 1.31%
+75,000
New +$1.72M
CAH icon
27
Cardinal Health
CAH
$55.5B
$2.45M 1.21%
+30,000
New +$2.36M
IMMU
28
DELISTED
Immunomedics Inc
IMMU
$2.27M 1.12%
350,000
+50,000
+17% +$253K
ACRS icon
29
Aclaris Therapeutics
ACRS
$868M
$2.24M 1.11%
75,000
+25,000
+50% +$721K
JUNO
30
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.22M 1.1%
+100,000
New +$2.14M
SPNC
31
DELISTED
Spectranetics Corp
SPNC
$2.18M 1.08%
75,000
-35,000
-32% -$933K
TVTY
32
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$2.18M 1.08%
75,000
-25,000
-25% -$660K
WBA
33
CALL
DELISTED
Walgreens Boots Alliance
WBA
$2.08M 1.03%
25,000
– –
MDRX
34
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.9M 0.94%
150,000
+90,000
+150% +$1.07M
LHCG
35
DELISTED
LHC Group LLC
LHCG
$1.89M 0.93%
35,000
+5,000
+17% +$243K
ZBH icon
36
Zimmer Biomet
ZBH
$18.7B
$1.83M 0.91%
15,450
-36,050
-70% -$4.09M
PCRX icon
37
Pacira BioSciences
PCRX
$974M
$1.82M 0.9%
+40,000
New +$1.73M
CCXI
38
DELISTED
ChemoCentryx, Inc.
CCXI
$1.82M 0.9%
250,000
-20,000
-7% -$144K
MZOR
39
DELISTED
Mazor Robotics Ltd.
MZOR
$1.73M 0.85%
58,000
-117,000
-67% -$2.76M
XENT
40
DELISTED
Intersect ENT, Inc
XENT
$1.72M 0.85%
100,000
+25,000
+33% +$350K
GILD icon
41
Gilead Sciences
GILD
$165B
$1.7M 0.84%
25,000
– –
ALDR
42
DELISTED
Alder Biopharmaceuticals
ALDR
$1.56M 0.77%
75,000
-65,000
-46% -$1.44M
AZN icon
43
AstraZeneca
AZN
$251B
$1.56M 0.77%
25,000
– –
AKAO
44
DELISTED
Achaogen Inc
AKAO
$1.51M 0.75%
60,000
+10,000
+20% +$205K
ANAB icon
45
AnaptysBio
ANAB
$1.64B
$1.39M 0.69%
+50,000
New +$1.16M
BIVV
46
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
$1.36M 0.67%
+25,000
New +$1.23M
BMY icon
47
CALL
Bristol-Myers Squibb
BMY
$132B
$1.36M 0.67%
+25,000
New +$1.37M
CTMX icon
48
CytomX Therapeutics
CTMX
$750M
$1.29M 0.64%
+75,000
New +$987K
EPZM
49
DELISTED
Epizyme, Inc
EPZM
$1.29M 0.64%
+75,000
New +$999K
IPXL
50
DELISTED
Impax Laboratories, Inc.
IPXL
$1.26M 0.63%
+100,000
New +$1.21M
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2017 Portfolio in Review

As of Q1 2017, Iguana Healthcare Management held 86 positions worth $202M, up 21% from $167M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management deployed $7.29M of net new capital in Q1 2017, opening 26 new positions and adding to 16 existing holdings. Its largest new stake was Shire pic: 61,250 shares worth $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 76% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Biogen, an estimated $7.07M trimmed.

  • Iguana Healthcare Management's largest Q1 2017 buy was Shire pic: 61,250 shares worth $10.7M.
  • Iguana Healthcare Management added most to Celgene Corp in Q1 2017, an estimated $1.2M increase.
  • Iguana Healthcare Management's biggest Q1 2017 reduction was Biogen, cutting an estimated $7.07M.
  • Iguana Healthcare Management fully exited Elevance Health in Q1 2017, selling an estimated $2.88M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $202M portfolio in Q1 2017.
  • Iguana Healthcare Management opened 26 new positions and closed 17 in Q1 2017.
  • Iguana Healthcare Management's portfolio value rose 21% quarter-over-quarter to $202M.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.